The Core Technology Platforms of SABC-HLP comprise four integrated capabilities: the Cryobank Platform, Stem Cell Standardization & GMP Platform, iPSC Platform, and Clinical Translation Platform. Together, these platforms provide the technological foundation of the SABC-HLP ecosystem by supporting the complete continuum of stem cell and regenerative medicine—from biological resource banking and standardized cell manufacturing to disease modeling, cell engineering, and clinical translation.
